Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Basic Res Cardiol ; 112(3): 20, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28258298

RESUMO

Inhibition of complement factor 5 (C5) reduced myocardial infarction in animal studies, while no benefit was found in clinical studies. Due to lack of cross-reactivity of clinically used C5 antibodies, different inhibitors were used in animal and clinical studies. Coversin (Ornithodoros moubata complement inhibitor, OmCI) blocks C5 cleavage and binds leukotriene B4 in humans and pigs. We hypothesized that inhibition of C5 before reperfusion will decrease infarct size and improve ventricular function in a porcine model of myocardial infarction. In pigs (Sus scrofa), the left anterior descending coronary artery was occluded (40 min) and reperfused (240 min). Coversin or placebo was infused 20 min after occlusion and throughout reperfusion in 16 blindly randomized pigs. Coversin significantly reduced myocardial infarction in the area at risk by 39% (p = 0.03, triphenyl tetrazolium chloride staining) and by 19% (p = 0.02) using magnetic resonance imaging. The methods correlated significantly (R = 0.92, p < 0.01). Tissue Doppler echocardiography showed increased systolic displacement (31%, p < 0.01) and increased systolic velocity (29%, p = 0.01) in coversin treated pigs. Interleukin-1ß in myocardial microdialysis fluid was significantly reduced (31%, p < 0.05) and tissue E-selectin expression was significantly reduced (p = 0.01) in the non-infarcted area at risk by coversin treatment. Coversin ablated plasma C5 activation throughout the reperfusion period and decreased myocardial C5b-9 deposition, while neither plasma nor myocardial LTB4 were significantly reduced. Coversin substantially reduced the size of infarction, improved ventricular function, and attenuated interleukin-1ß and E-selectin in this porcine model by inhibiting C5. We conclude that inhibition of C5 in myocardial infarction should be reconsidered.


Assuntos
Complemento C5/antagonistas & inibidores , Infarto do Miocárdio/patologia , Animais , Proteínas de Artrópodes/farmacologia , Proteínas de Transporte/farmacologia , Modelos Animais de Doenças , Ecocardiografia , Imunofluorescência , Imageamento por Ressonância Magnética , Distribuição Aleatória , Sus scrofa
2.
Acta Anaesthesiol Scand ; 56(7): 914-9, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22571443

RESUMO

BACKGROUND: Axillary block is the most commonly performed brachial plexus block and may be guided by nerve stimulation or ultrasound. Magnetic resonance imaging (MRI) has proven to be beneficial in presenting anatomy of interest for regional anaesthesia and in demonstrating spread of local anaesthetic. The aim of this pilot study was to demonstrate the anatomy as shown by MRI of the brachial plexus in the axillary region. METHODS: Nine volunteers and nine patients were examined in a 3.0 Tesla MR. The patients had two different brachial plexus blocks. Subsequently, they were scanned by MRI and finally tested clinically for block efficacy before operation. Axial images, with and without local anaesthetics injected, were viewed in a sequence loop to identify the anatomy. RESULTS: With the high-resolution MRI, we obtained images of good quality, and cords and all terminal nerves could be identified. When local anaesthetics are injected, neurovascular structures are displaced, and the vein is compressed. Viewing the images in a sequence loop facilitates identification of the different nerves and has high instructive value (links S1-3 to these loops are enclosed). CONCLUSION: Clinical high-field 3.0 Tesla MRI scanner gives good visualization of brachial plexus in the axilla. The superior ability to detect local anaesthetics after it has been injected and the multiplanar imaging capability make MRI a useful tool in studies of the brachial plexus.


Assuntos
Anestésicos Locais/farmacologia , Axila/inervação , Plexo Braquial/anatomia & histologia , Imageamento por Ressonância Magnética/métodos , Bloqueio Nervoso/métodos , Anestésicos Locais/farmacocinética , Axila/irrigação sanguínea , Artéria Axilar/ultraestrutura , Veia Axilar/ultraestrutura , Plexo Braquial/efeitos dos fármacos , Bupivacaína/farmacocinética , Bupivacaína/farmacologia , Humanos , Injeções , Mepivacaína/farmacocinética , Mepivacaína/farmacologia , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/inervação , Projetos Piloto , Pressão , Nervo Radial/ultraestrutura
3.
Magn Reson Med ; 57(1): 22-8, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17152088

RESUMO

Quantification of intramyocellular lipids (IMCL) in obese subjects by single-voxel spectroscopy (SVS) or conventional spectroscopic imaging (SI) often fails due to overlap of IMCL spectral lines by extramyocellular lipids (EMCL), and signal contamination from subcutaneous fat and bone marrow. This study demonstrates that these problems can be solved by high-resolution SI with 128 phase-encoding steps and a read gradient during acquisition. The small voxels obtained in this way facilitated differentiation between EMCL and IMCL. This method offers the possibility of studying different muscle groups and the variation of lipids within one muscle.


Assuntos
Lipídeos/análise , Espectroscopia de Ressonância Magnética/métodos , Fibras Musculares Esqueléticas/química , Músculo Esquelético/química , Obesidade , Adulto , Índice de Massa Corporal , Feminino , Humanos , Aumento da Imagem , Perna (Membro) , Pessoa de Meia-Idade , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/metabolismo , Valores de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA